Association of CD98, integrin β1, integrin β3 and Fak with the progression and liver metastases of colorectal cancer

Pathology Research and Practice

Volumn 210, Issue 10, 2014, Pages 668-674

  Sun, Cuicui ^a   Zargham, Ramin ^b   Shao, Qin ^b   Gui, Xianyong ^c   Marcus, Victoria ^b   Lazaris, Anthoula ^b   Salman, Ayat ^b   Metrakos, Peter ^b   Qu, Xianjun ^d   Gao, Zuhua ^b,d  

^a SHANDONG UNIVERSITY   (China)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

CD98; Colorectal cancer; Fak; Integrin; Liver metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; BETA1 INTEGRIN; BETA3 INTEGRIN; CD98 ANTIGEN; FOCAL ADHESION KINASE; ANTIGENS, CD29; ANTIGENS, CD98; FOCAL ADHESION KINASE 1; INTEGRIN BETA3; PTK2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CELL BUDDING; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR LOCALIZATION; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SECONDARY; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD29; ANTIGENS, CD98; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; FEMALE; FOCAL ADHESION KINASE 1; HUMANS; INTEGRIN BETA3; LIVER NEOPLASMS; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION;

EID: 84908067575     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.06.016     Document Type: Article

References (29)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127:2893-2917.
2. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer. J. Clin. 2011, 61:69-90.
3. Cathcart M.C., Lysaght J., Pidgeon G.P. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention. Cancer Metastasis Rev. 2011, 30:363-385.
4. Shureiqi I., Lippman S.M. Lipoxygenase modulation to reverse carcinogenesis. Cancer Res. 2001, 61:6307-6312.
5. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J. Clin. 2012, 62:10-29.
6. Cameron J.L., Riall T.S., Coleman J., Belcher K.A. One thousand consecutive pancreaticoduodenectomies. Ann. Surg. 2006, 244:10-15.
7. Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 2010, 10:9-22.
8. McLean G.W., Carragher N.O., Avizienyte E., Evans J., Brunton V.G., Frame M.C. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat. Rev. Cancer 2005, 5:505-515.
9. Devés R., Boyd C.A. Surface antigen CD98(4F2): not a single membrane protein, but a family of proteins with multiple functions. J. Membr. Biol. 2000, 173:165-177.
10. Yan Y., Vasudevan S., Nguyen H.T., Merlin D. Intestinal epithelial CD98: an oligomeric and multifunctional protein. Biochim. Biophys. Acta 2008, 1780:1087-1092.
11. Feral C.C., Nishiya N., Fenczik C.A., Stuhlmann H., Slepak M., Ginsberg M.H. CD98hc (SLC3A2) mediates integrin signalling. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:355-360.
12. Ichinoe M., Mikami T., Yoshida T., Igawa I., Tsuruta T., Nakada N., Anzai N., Suzuki Y., Endou H., Okayasu I. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions. Pathol. Int. 2011, 61:281-289.
13. Gao J., Hu Z.H., Liu D.W., Liu J.J., Liu C., Hou R., Gao S., Zhang D.Y., Zhang S.L., Lin B. Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance. J. Exp. Clin. Cancer Res. 2013, 32:36.
14. Kaira K., Sunose Y., Arakawa K., Ogawa T., Sunaga N., Shimizu K., Tominaga H., Oriuchi N., Itoh H., Nagamori S., Kanai Y., Segawa A., Furuya M., Mori M., Oyama T., Takeyoshi I. Prognostic significance of L-type amino acid transported expression in surgically resected pancreatic cancer. Br. J. Cancer 2012, 107:632-638.
15. Brandner J.M., Haass N.K. Melanoma's connections to the tumour microenvironment. Pathology 2013, 45:443-452.
16. Henderson N.C., Collis E.A., Mackinnon A.C., Simpson K.J., Haslett C., Zent R., Ginsberg M., Sethi T. CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J. Biol. Chem. 2004, 279:54731-54741.
17. Féral C.C., Zijlstra A., Tkachenko E., Prager G., Gardel M.L., Slepak M., Ginsberg M.H. CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling. J. Cell Biol. 2007, 178:701-711.
18. Verrey L.F. System, heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch. 2003, 445:529-533.
19. Reynolds B., Laynes R., Ogmundsdóttir M.H., Boyd C.A., Goberdhan D.C. Amino acid transporters and nutrient-sensing mechanisms: new targets for treating insulin-linked disorders. Biochem. Soc. Trans. 2007, 35:1215-1217.
20. Rintoul R.C., Buttery R.C., Mackinnon A.C., Wong W.S., Mosher D., Haslett C., Sethi T. Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. Mol. Biol. Cell 2002, 13:2841-2852.
21. Jaakkola I., Merinen M., Jalkanen S., Hänninen A. Ly6C Induces Clustering of LFA-1 (CD11a/CD18) and is involved in subtype-specific adhesion of CD8 T cells. J. Immunol. 2003, 170:1283-1290.
22. Brakebusch C., Fassler R. Beta 1 integrin function in vivo: adhesion, migration and more. Cancer Metastasis Rev. 2005, 24:403-411.
23. Dingemans A.M., van den Boogaart V., Vosse B.A., van Suylen R.J., Griffioen A.W., Thijssen V.L. Integrin expression profiling identifies integrin a5 and β1 as prognostic factors in early stage non-small cell lung cancer. Mol. Cancer 2010, 9:152.
24. Wiktorska M., Sacewicz-Hofman I., Stasikowska-Kanicka O., Danilewicz M., Niewiarowska J. Distinct inhibitory efficiency of siRNAs and DNAzymes to β1 integrin subunit in blocking tumor growth. Acta Biochim. Pol. 2013, 60:77-82.
25. Steri V., Ellison T.S., Gontarczyk A.M., Weilbaecher K., Schneider J.G., Edwards D., Fruttiger M., Hodivala-Dilke K.M., Robinson S.D. Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice. Circ. Res. 2013, 114:79-91.
26. Parsons J.T. Focal adhesion kinase: the first ten years. J. Cell Sci. 2003, 116:1409-1416.
27. Romer L.H., Birukov K.G., Garcia J.G. Focal adhesions: paradigm for a signaling nexus. Circ. Res. 2006, 98:606-616.
28. Vermeulen P.B., Colpaert C., Salgado R., Hellemans H., Van Den Heuvel E., Goovaerts G., Dirix L.Y., Van Marck E. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J. Pathol. 2001, 195:336-342.
29. Illemann M., Bird N., Majeed A., Laerum O.D., Lund L.R., Danø K., Nielsen B.S. Two distinct expression patterns of urokinase, rokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases. Int. J. Cancer 2009, 124:1860-1870.